Rebecca R Vanderpool
Overview
Explore the profile of Rebecca R Vanderpool including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1431
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Precision Medicine for Pulmonary Vascular Disease: The Future Is Now (2023 Grover Conference Series)
Forbes L, Bauer N, Bhadra A, Bogaard H, Choudhary G, Goss K, et al.
Pulm Circ
. 2025 Jan;
15(1):e70027.
PMID: 39749110
Pulmonary vascular disease is not a single condition; rather it can accompany a variety of pathologies that impact the pulmonary vasculature. Applying precision medicine strategies to better phenotype, diagnose, monitor,...
2.
Miller A, Vanderpool R
Heart Fail Clin
. 2024 Nov;
21(1):111-117.
PMID: 39550074
Cardiopulmonary exercise testing is an active research area in patients with unexplained dyspnea, heart failure, and pulmonary hypertension. Focus has centered on the use of novel hemodynamic parameters to further...
3.
Shelburne N, Nian H, Beck G, Casanova N, Desai A, DuBrock H, et al.
CHEST Pulm
. 2024 Nov;
2(3).
PMID: 39524046
Background: Sex-based differences are important in the development and progression of pulmonary arterial hypertension. However, it is not established whether these differences are generalizable to all forms of pulmonary hypertension...
4.
Vanderpool R
Am J Respir Crit Care Med
. 2024 Jul;
210(9):1075-1077.
PMID: 39012204
No abstract available.
5.
Morland K, Gerges C, Elwing J, Visovatti S, Weatherald J, Gillmeyer K, et al.
Pulm Circ
. 2023 Dec;
13(4):e12317.
PMID: 38144948
This manuscript on real-world evidence (RWE) in pulmonary hypertension (PH) incorporates the broad experience of members of the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative Real-World Evidence Working Group....
6.
Janowski A, Ravellette K, Insel M, Garcia J, Rischard F, Vanderpool R
J Heart Lung Transplant
. 2023 Dec;
43(5):755-770.
PMID: 38141893
Background: Quantifying right ventricular (RV) function is important to describe the pathophysiology of in pulmonary hypertension (PH). Current phenotyping strategies in PH rely on few invasive hemodynamic parameters to quantify...
7.
Adly G, Mithoefer O, Elliott Epps J, Hajj J, Hambright E, Jackson G, et al.
ASAIO J
. 2023 Oct;
70(2):99-106.
PMID: 37816019
Right ventricular failure contributes significantly to morbidity and mortality after left ventricular assist device implantation. Recent data suggest a less invasive strategy (LIS) via thoracotomy may be associated with less...
8.
Elliott J, Menakuru N, Martin K, Rahaghi F, Rischard F, Vanderpool R
J Am Heart Assoc
. 2023 Oct;
12(20):e029667.
PMID: 37815026
Background Pulmonary vascular distensibility associates with right ventricular function and clinical outcomes in patients with unexplained dyspnea and pulmonary hypertension. Alpha distensibility coefficient is determined from a nonlinear fit to...
9.
Fauvel C, White R, Vanderpool R, Badagliacca R, Tobore T, Rahman M, et al.
Chest
. 2023 Sep;
165(2):431-436.
PMID: 37709252
No abstract available.
10.
Rischard F, Bernardo R, Vanderpool R, Kwon D, Acharya T, Park M, et al.
Circ Heart Fail
. 2023 Sep;
16(10):e010555.
PMID: 37664964
Background: Normative changes in right ventricular (RV) structure and function have not been characterized in the context of treatment-associated functional recovery (RV functional recovery [RVFnRec]). The aim of this study...